Maria de Lourdes (Malú) Gámez Tansey, PhD

Malú Gámez Tansey, Ph.D. is the James A. Caplin MD, Chair in Alzheimer’s Disease and Professor of Neurology, Director of Neuroimmunology Research Group, and Executive Associate Director of Education at the Stark Neuroscience Research Institute at Indiana University School of Medicine. She investigates the role of central-peripheral immune crosstalk (including the gut-brain axis) in brain health and aging within the context of age-related neurodegenerative diseases like Parkinson’s and Alzheimer’s with the long-term goal of developing better therapies for patients. Dr. Tansey obtained her B.S/M.S in Biological Sciences from Stanford University and her Ph.D. in Cell Regulation from UT Southwestern followed by post-doctoral work in neuroscience at Washington University. As head of Chemical Genetics at Xencor, she co-invented novel soluble TNF inhibitors that have now advanced to clinical trials in Alzheimer’s disease.